Nuclear beta-catenin expression was observed in 42.6% of the samples, similar to thatfound by Morikawa et al, where the positivity of this marker was recorded in 323(47%) of 724 cases of CRC.18 Here, CTNNB1 is linked to colorectal carcinoma.